Document Detail

Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma.
MedLine Citation:
PMID:  11031408     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To determine the correlation between the expression of CD44 variant exon 6 (v6) and the clinicopathological features of head and neck squamous cell carcinomas (HNSCCs), and to study the role of CD44v6 in cell invasion using a human HNSCC cell line (HSC-2). DESIGN: The expression of CD44v6 was evaluated using immunohistochemical analysis in paraffin-embedded tissue specimens from 89 primary lesions. The concentration of CD44v6 protein in 37 cryopreserved tumor specimens was evaluated using the enzyme-linked immunosorbent assay. The HSC-2 cells were treated with 2F10, a monoclonal antibody against CD44v6. The effects of 2F10 on HSC-2 cell proliferation, migration, and invasion potential were evaluated. RESULTS: The down-regulation of CD44v6 expression or the concentration of cancer tissue significantly correlated with a lower degree of pathohistological differentiation and a higher rate of cervical metastasis. The invasion of HSC-2 cells into type I collagen gel and the expression of CD44v6 were decreased in invading cells released from the upper layer. Furthermore, the treatment of HSC-2 cells with 2F10 significantly enhanced cell invasion. However, 2F10 did not affect either the proliferation or migration properties of HSC-2 cells. CONCLUSIONS: The down-regulation of CD44v6 expression may be useful as a biological marker for the degree of malignancy in HNSCCs. We assume that the loss or dysfunction of CD44v6 is involved in the acquisition of invasion ability in HSC-2 cells. In addition, the potential existence of a CD44v6-mediated signal transduction pathway may play a role in inhibiting the invasion in HNSCCs.
M Kanke; M Fujii; K Kameyama; J Kanzaki; Y Tokumaru; Y Imanishi; T Tomita; Y Matsumura
Related Documents :
19185988 - Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes.
1995798 - Blood cell proliferation response to beryllium: analysis by receiver-operating characte...
20977428 - Effects of yc-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carc...
7196878 - Carcinoma of the oesophagus with spindle cell features.
2466188 - Liver cell rosettes: structural differences in cholestasis and hepatitis.
19356858 - Radioactive egfr antibody cetuximab in multimodal cancer treatment: stability and syner...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of otolaryngology--head & neck surgery     Volume:  126     ISSN:  0886-4470     ISO Abbreviation:  Arch. Otolaryngol. Head Neck Surg.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-30     Completed Date:  2000-10-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8603209     Medline TA:  Arch Otolaryngol Head Neck Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1217-23     Citation Subset:  AIM; IM    
Department of Otolaryngology-Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD44 / genetics*
Biological Markers / analysis
Carcinoma, Squamous Cell / genetics*,  pathology*
Enzyme-Linked Immunosorbent Assay
Head and Neck Neoplasms / genetics*,  pathology*
Neoplasm Invasiveness / genetics*
Tumor Cells, Cultured
Reg. No./Substance:
0/Antigens, CD44; 0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Results of larynx preservation surgery for advanced laryngeal cancer through tracheal autotransplant...
Next Document:  Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a...